Key Insights

• Corbus Pharmaceuticals Holdings' significant retail investors ownership suggests that the key decisions are influenced by shareholders from the larger public

• 27% of the business is held by the top 25 shareholders

• Ownership research, combined with past performance data can help provide a good understanding of opportunities in a stock

If you want to know who really controls Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), then you'll have to look at the makeup of its share registry. With 32% stake, retail investors possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk).

As a result, retail investors were the biggest beneficiaries of last week’s 214% gain.

Let's take a closer look to see what the different types of shareholders can tell us about Corbus Pharmaceuticals Holdings.

See our latest analysis for Corbus Pharmaceuticals Holdings

What Does The Institutional Ownership Tell Us About Corbus Pharmaceuticals Holdings?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

We can see that Corbus Pharmaceuticals Holdings does have institutional investors; and they hold a good portion of the company's stock. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Corbus Pharmaceuticals Holdings, (below). Of course, keep in mind that there are other factors to consider, too.

It would appear that 9.3% of Corbus Pharmaceuticals Holdings shares are controlled by hedge funds. That's interesting, because hedge funds can be quite active and activist. Many look for medium term catalysts that will drive the share price higher. Tang Capital Management, LLC is currently the largest shareholder, with 9.6% of shares outstanding. Ikarian Capital, LLC is the second largest shareholder owning 4.4% of common stock, and The Vanguard Group, Inc. holds about 4.1% of the company stock.

On studying our ownership data, we found that 25 of the top shareholders collectively own less than 50% of the share register, implying that no single individual has a majority interest.

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There is some analyst coverage of the stock, but it could still become more well known, with time.